Navigation Links
Bond Laboratories' First Quarter Fiscal 2008 Sales Exceeding Internal Projections

SAN DIEGO, March 27 /PRNewswire-FirstCall/ -- Bond Laboratories (OTC Bulletin Board: BNLB) is pleased to announce that sales of its Fusion 6+ Hour Energy Shot, which began shipping at the beginning of this year, have exceeded the company's internal projections for each month of the first quarter of 2008.

Fusion's 6+ Hour Energy Shot was first introduced at the National Convenience Store show in Atlanta this past November, where it was voted "Best Tasting Shot". Fusion began shipping the first week in January. "We have been getting numerous inquiries from shareholders regarding our sales growth as well as the number of distribution partners we have currently established relationships with. I am pleased to announce we have exceeded our internal sales projections, as well as our anticipated list of distribution partners", said Eric Schick, President of Bond.

We will provide more detailed information as to our progress in April, after Bond Laboratories has had an opportunity to file its first quarterly report for 2008.

About Bond Laboratories:

Bond Laboratories is a premier marketer and manufacturer of nationally branded nutritional products. Bond has brought together a seasoned team of highly successful sales and marketing executives with considerable experience in the launch and development of many well known branded products. With our previous nutraceutical and pharmaceutical sales and management expertise, Bond Laboratories, Inc. is currently focused on developing proprietary products, as well as delivery platforms, that address the needs and concerns of today's consumer. For more information on Fusion(TM) Energy Products, interested persons can go to

Safe Harbor

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward- looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management.

Contact: Scott Landow Phone: 858.847.9000 Fax: 858.847.9090

SOURCE Bond Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. STMicroelectronics and Veredus Laboratories Launch Markets First Lab-on-Chip for Rapid Molecular Flu Detection at Point of Need
2. Forest Laboratories Announces Resignation of Ivan Gergel, MD
3. Dr. Wei Sun, PhD, MD Joins SpectraCell Laboratories
4. Stiefel Laboratories, Inc. Appoints New President
5. Mylan Announces Appointment of Jagdish Dore as CEO and Managing Director of Matrix Laboratories
6. IDEXX Laboratories Announces Increase in Share Repurchase Program
7. Charles River Laboratories International Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
8. Caraco Pharmaceutical Laboratories Ltd. to Market Generic Protonix(R)
9. IDEXX Laboratories Announces Fourth Quarter Results
10. IDEXX Laboratories to Release 2007 Fourth Quarter and Full-Year Financial Results
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
Post Your Comments:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: